Plasma Von Willebrand factor (vWF) assay compared to Prothrombin time (PT/INR), aPTT and Platelets as predictor of outcome in Alcoholic-Acute-on-chronic-liver failure (A-ACLF)

Plasma Von Willebrand factor (vWF) assay compared to Prothrombin time (PT/INR), aPTT and Platelets as predictor of outcome in Alcoholic-Acute-on-chronic-liver failure (A-ACLF) - Plasma Von Willebrand factor (vWF) assay compared to Prothrombin time (PT/INR), aPTT and Platelets as predictor of outcome in Alcoholic-Acute-on-chronic-liver failure (A-ACLF)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036660

Enrollment

Registered

2019-05-07

Start date

2018-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute on Chronic Liver failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Retrospective data of patients who presented as Alcohol related Acute on Chronic Liver Failure admitted in hepatology department were taken for this study.

Exclusion criteria

Exclusion criteria: Patients with hepatocellular carcinoma or portal vein thrombosis and those unwilling to participate were excluded from this study. Pregnant women and children were also excluded.

Design outcomes

Primary

Measure	Time frame
To establish von Willebrand factor (vWf) assay as predictor of inhospital outcome in patients with Alcoholic ACLF.	—

Secondary

Measure	Time frame
Compare the predicting ability of vWf to other pre-existing markers of liver disease severity and other coagulation parameters.	—

Countries

Asia(except Japan)

Contacts

Public ContactPratap Tiwari

Christian Medical College Hepatology

pratapsagartiwari@gmail.com91-9152160634

Outcome results